Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Vestn Oftalmol ; 139(1): 69-74, 2023.
Artículo en Ruso | MEDLINE | ID: mdl-36924516

RESUMEN

Coats disease (OMIM 300216) is a form of hereditary retinal dystrophy, which occurs due to congenital abnormality of retinal vessels and features unilateral exudative vitreoretinopathy. Coats disease mostly occurs sporadically; its genetic cause is still undetermined. Molecular genetic research including whole exome sequencing by the NGS method was used to define a genetic cause of the observed phenotype. Two heterozygous variants in different genomic loci associated with other forms of hereditary retinal dystrophy were detected, a rare variant in the HMCN1 gene c.9571C>T, p.(Arg3191Cys), and a known pathogenic variant in the NPHP4 gene c.2930C>T, p.(Thr977Met). The HMCN1 gene is responsible for dominant age-related macular degeneration (OMIM 603075), pathogenic variants in the NPHP4 gene cause recessive Senior-Løken syndrome 4 (OMIM 266900). These genes encode the proteins that are involved in the regulation of integrity of the blood-retinal barrier in the vascular endothelium (NPHP4) and retinal pigment epithelium (HMCN1). The identified mutation in the NPHP4 gene could lead to decreased function of the NPHP4 protein and contribute to the development of retinal degeneration, potentially of oligogenic nature.


Asunto(s)
Distrofias Retinianas , Telangiectasia Retiniana , Retinitis Pigmentosa , Humanos , Distrofias Retinianas/diagnóstico , Distrofias Retinianas/genética , Mutación , Linaje , Biología Molecular
2.
Vestn Oftalmol ; 137(1): 68-73, 2021.
Artículo en Ruso | MEDLINE | ID: mdl-33610152

RESUMEN

The article describes a clinical case of a 14-year old patient with RDH5 mutations (OMIM *601617) in patient with fundus albipunctatus (OMIM #136880) and characteristic biomarkers of this disease with previously described pathogenic variant of nucleotic sequence in exon 3 of the RDH5 gene (NM_002905.3:c.500G>A), causing a missense change (p.Arg167His) in heterozygous state and previously not described pathogenic variant of nucleotic sequence in exon 5 of the RDH5 gene (NM_002905.3:c.838C>T), leading to a missense change (p.Arg280Cys) in heterozygous state with characteristic biomarkers of the disease. Best-corrected visual acuity (BCVA) was 20/20. Nyctalopia was accompanied by reduced b-wave of scotopic (dark-adapted 0.01) ERG and decreased amplitude of a- and b-waves of maximum (dark-adapted 3) ERG. Decreased amplitude of the a- and b-waves of photopic (light-adapted 3) ERG and the amplitude of high-frequency (light-adapted 30 Hz) Flicker ERG shows the involvement of retinal cone system in the process. Fundus autofluorescence imaging of both eyes produced fuzzy and grainy images with slight hyperfluorescence of retinal flecks. Optical coherence tomography showed focal thickening centered in the photoreceptor outer segment corresponding to the multiple discrete albipunctate dots.


Asunto(s)
Electrorretinografía , Ceguera Nocturna , Adolescente , Oxidorreductasas de Alcohol/genética , Humanos , Mutación , Enfermedades de la Retina , Tomografía de Coherencia Óptica
3.
Vestn Otorinolaringol ; 85(4): 65-69, 2020.
Artículo en Ruso | MEDLINE | ID: mdl-32885640

RESUMEN

Congenital hearing loss is one of the most frequent inherited human pathologies, occurring in 1-2 out of 1000 newborns. X-linked hearing loss occurs in 1-5% of all congenital hearing impairments. The proband (a man) and his affected brother have profound prelingual non-syndromic neurosensory hearing loss. Their parents are healthy. The aim of the study was to determine the cause of hearing loss in a given family and to assess the population frequency of the revealed pathogenic genetic variant. NGS analysis identified a pathogenic variant c.907C>T (p.Pro303Ser) in the POU3F4 gene mapped to the Xq21.1 locus. This is the second case of X-linked hearing loss (DFNX2, OMIM 304400) in Europe, caused by the c.907C>T variant in the POU3F4 gene. DFNX2-hearing loss is manifested with abnormalities of the inner ear, predisposing to the "gusher effect" - otoliquorrhea during stapedoplasty. The brother was diagnosed with a c.907C>T variant in the POU3F4 gene in the hemizygous state while in their mother - in the heterozygous state. Their father had no variant c.907C>T. Molecular genetic analysis showed that the genetic variant c.907C>T was not detected in the control sample of healthy female from the Nogai population, which suggests its low frequency in the population.


Asunto(s)
Pérdida Auditiva Sensorineural , Pérdida Auditiva , Europa (Continente) , Femenino , Humanos , Recién Nacido , Masculino , Factores del Dominio POU/genética , Linaje
4.
BMC Med Genet ; 20(1): 44, 2019 03 21.
Artículo en Inglés | MEDLINE | ID: mdl-30898088

RESUMEN

BACKGROUND: Cystic fibrosis (CF; OMIM #219700) is a common autosomal recessive disease caused by pathogenic variants (henceforward mutations) in the cystic fibrosis transmembrane conductance regulator gene (CFTR). The spectrum and frequencies of CFTR mutations vary among different populations. Characterization of the specific distribution of CFTR mutations can be used to optimize genetic counseling, foster reproductive choices, and facilitate the introduction of mutation-specific therapies. Chechens are a distinct Caucasian ethnic group of the Nakh peoples that originated from the North Caucasus. Chechens are one of the oldest ethnic groups in the Caucasus, the sixth largest ethnic group in the Russian Federation (RF), and constitute the majority population of the Chechen Republic (Chechnya). The spectrum of CFTR mutations in a representative cohort of Chechen CF patients and healthy individuals was analyzed. METHODS: Molecular genetic analysis of 34 CFTR mutations (representing approx. 80-85% of mutations in multiethnic CF populations of the RF) was performed in 32 CF patients from 31 unrelated Chechen families living in Chechnya. One hundred randomly chosen healthy Chechens were analyzed for the 15 most common "Russian" mutations. The clinical symptoms in Chechen CF patients with different CFTR genotypes were investigated. RESULTS: High frequencies of c.1545_1546delTA (p.Tyr515X; 1677delTA) (52 out of 64 CFTR alleles tested; 81.3%) and c.274G > A (p.Glu92Lys, E92K) (8/64, 12.5%) mutations were found. Twenty patients were homozygous for the c.1545_1546delTA mutation, and eight were compound heterozygous for the c.1545_1546delTA and c.274G > A mutations. Three carriers of the c.1545_1546delTA mutation were also found in the cohort of 100 apparently healthy Chechens (frequency - 0.015). The c.1545_1546delTA and c.274G > A mutations are linked to the same haplotype (22-7-16-13) of intragenic Short Tandem Repeat markers, i.e., IVS1CA, IVS6aGATT, IVS8CA, and IVS17bCA. CONCLUSIONS: The distribution of CFTR mutations in the Chechen CF population is unique regarding the high frequency of mutations c.1545_1546delTA and c.274G > A (more than 90% of the mutant alleles). The c.274G > A mutation is associated with a less severe course of CF than that observed in c.1545_1546delTA homozygotes. Testing for these two variants can be proposed as the first step of CF DNA diagnosis in the Chechen population.


Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Fibrosis Quística/genética , Mutación Puntual , Eliminación de Secuencia , Adolescente , Estudios de Casos y Controles , Niño , Preescolar , Fibrosis Quística/etnología , Diagnóstico Precoz , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Humanos , Lactante , Recién Nacido , Masculino , Federación de Rusia/etnología , Índice de Severidad de la Enfermedad
5.
Clin Genet ; 92(6): 639-644, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28321846

RESUMEN

Congenital aniridia is a severe autosomal dominant congenital panocular disorder, mainly associated with pathogenic variants in the PAX6 gene. The objective of the study was to investigate the mutational and clinical spectra of congenital aniridia in a cohort of 117 patients from Russia. Each patient underwent detailed ophthalmological examination. From 91 unrelated families, 110 patients were diagnosed with congenital aniridia and 7 with WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation syndrome). The clinical presentation in aniridia patients varied from the complete bilateral absence of the iris (75.5%) to partial aniridia or iris hypoplasia (24.5%). Additional ocular abnormalities were consistent with previous reports. In our cohort, we saw a previously not described high percentage of patients (45%) who showed non-ocular phenotypes. Prevalence of deletions coherent with WAGR syndrome appeared to be 19.4% out of sporadic patients. Among the other aniridia cases, PAX6 deletions were identified in 18 probands, and small intragenic changes were detected in 58 probands with 27 of these mutations being novel and 21 previously reported. In 3 families mosaic mutation was transmitted from a subtly affected parent. Therefore, PAX6 mutations explained 96.7% of aniridia phenotypes in this study with only 3 of 91 probands lacking pathogenic variants in the gene.


Asunto(s)
Aniridia/genética , Predisposición Genética a la Enfermedad , Mutación , Factor de Transcripción PAX6/genética , Síndrome WAGR/genética , Adulto , Alelos , Aniridia/diagnóstico , Aniridia/patología , Estudios de Cohortes , Exones , Femenino , Expresión Génica , Humanos , Lactante , Patrón de Herencia , Intrones , Masculino , Fenotipo , Federación de Rusia , Índice de Severidad de la Enfermedad , Síndrome WAGR/diagnóstico , Síndrome WAGR/patología
6.
Arkh Patol ; 76(5): 3-12, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25543402

RESUMEN

OBJECTIVE: To determine the genetic forms of follicular cell thyroid carcinoma (FCTC) (papillary and follicular thyroid carcinoma (PTC and FTC)), to identify criteria to individually predict the development of the same disease for relatives, and to assess the role of molecular markers in the diagnosis, prognosis, and treatment of this disease. SUBJECTS AND METHODS: One hundred and ninety adult patients aged 20 to 84 years with histologically verified PTC and FTC and 20 children (12 patients with PTC and 8 with benign thyroid tumors) aged 2 to 16 years were examined. To assess the role of the BRAF gene as a molecular marker for thyroid carcinoma, DNA was isolated from the thyroid tumor tissue of 29 patients, which had been obtained by fine-needle aspiration biopsy (FNAB) and scraping and swabbing the cytological specimen previously showing an area containing tumor cells. A BRAF c.1799T>A (p.V600E) mutation in the FNAB specimens was tested by allele-specific ligation, followed by PCR amplification. RESULTS: The examinees' families were found to have a segregation of benign thyroid tumor and nontumor diseases (13.6%). Neoplasias of different sites were observed in 15% of the patients' relatives. Multiple primary tumors were detected in 6.1% of the patients and in 25% of the examined children (3/12). PTC was ascertained to accumulate as two clinical forms in the families. One form belongs to familial PTC (FPTC) in which two or three generations of relatives in the family are afflicted by only PTC and have a more severe phenotype of the disease. The other includes an association of FPTC with papillary kidney cancer. Furthermore, FPTC and PTC may be a component of multitumor syndromes, such as multiple endocrine neoplasia type 1, Cowden syndrome, and familial adenomatous polyposis. The familial hereditary forms of FCTC were generally revealed in 4.2% of the patients. BRAF v600E mutations were found in only 3 patients with Stages II and III PTC and were not in all the 12 children with PTC. CONCLUSION: The found clinical manifestation of the hereditary forms of FCTC permits the identification of people at high risk for this disease. No correlation between somatic BRAF mutations with a less favorable course in PTC can be noticed because there are few observations. Analysis of published data on the role of molecular markers in FCTC has shown that the existing specific somatic changes complement information in the differential cytological diagnosis when examining FNAB specimens.


Asunto(s)
Adenocarcinoma Folicular/genética , Carcinoma/genética , Patología Molecular , Proteínas Proto-Oncogénicas B-raf/genética , Neoplasias de la Tiroides/genética , Adenocarcinoma Folicular/diagnóstico , Adenocarcinoma Folicular/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biopsia con Aguja Fina , Carcinoma/diagnóstico , Carcinoma/patología , Carcinoma Papilar , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Linaje , Mutación Puntual , Polimorfismo de Nucleótido Simple , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides/diagnóstico , Neoplasias de la Tiroides/patología
7.
Mol Biol (Mosk) ; 48(5): 859-67, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25842872

RESUMEN

The generation of true random and pseudorandom control sequences is an important problem of computational biology. Available random sequence generators differ in underlying probabilistic models that often remain undisclosed to users. Random sequences produced by differing probabilistic models substantially differ in their outputs commonly used as baselines for evaluations of the motif frequencies. Moreover, modern bioinformatics studies often require generation of matching control transcriptome with emulated partitions into ORFs, 5'- and 3'-UTRs as well as the proportion of non-coding RNAs within model transcriptome rather than relatively simple continuous control sequences. Here we describe novel random sequence generating tool RANDTRAN that accounts for the length distribution of 5' and 3' non-translated regions in given transcriptome and the partition-specific di- and trinucleotide compositions in translated and non-translated regions. RANDRAN presents matching control transcriptomes in ready-to-use UCSC genome browser-compatible input files. These features may be useful for generating of control sequence sets for common types of computational analysis of various sequence motifs within various sets of RNA. RANDTRAN is available for free download at http://www.genereseairch.ru/images/Randtran.rar.


Asunto(s)
Biología Computacional , Células Eucariotas , ARN Mensajero , Programas Informáticos , Transcriptoma , Regiones no Traducidas 3' , Regiones no Traducidas 5' , Algoritmos , Sistemas de Lectura Abierta , Distribución Aleatoria
8.
Mol Biol (Mosk) ; 46(3): 371-86, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22888628

RESUMEN

Gene-directed therapy with small interfer-ring RNA (siRNA) has a tremedous potential and in the future will undoubtly occupy one of the leading positions among other therapeutic methods. The lack of efficient and targeted delivery vectors delays the successful implementation of this method in clinic. To develop such systems, one needs a comprehansive insight into the processes of interactions between siRNAs, its delivery systems and an organism. This review covers properties of therapeutic siRNAs and non-viral systems for their delivery.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Terapia Genética , Interferencia de ARN , ARN Interferente Pequeño/química , Aptámeros de Nucleótidos/química , Hemorreología , Humanos , Liposomas/química , Nanopartículas/química , Tamaño de la Partícula , ARN Interferente Pequeño/genética , Electricidad Estática
9.
Mol Biol (Mosk) ; 46(3): 387-401, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22888629

RESUMEN

To date, RNA interference remains the most powerful and promising tool for gene-targeted therapy. Several problems still have to be solved for its successful use in clinics. One of the main issues is the siRNA's efficient delivery. This review covers various types of nonviral siRNA delivery systems.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Terapia Genética , Interferencia de ARN , ARN Interferente Pequeño/química , Aptámeros de Nucleótidos/química , Materiales Biocompatibles/química , Humanos , Lípidos/química , Lipopéptidos/química , Liposomas/química , Nanopartículas/química , Polímeros/química , ARN Interferente Pequeño/genética , Electricidad Estática
10.
Mol Biol (Mosk) ; 42(4): 581-7, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-18856057

RESUMEN

Antisense regulation of gene expression is a widespread but poorly understood mechanism of gene expression regulation. The potential role of antisense transcripts in tumorigenesis is the most intriguing for the functional research. Here we experimentally characterize an antisense mRNA asLZK overlapping human MAP3K13/LZK gene that is involved in mitogenesis related JNK/SAPK signal transduction pathway. According to the functional annotation of the human genome, asLZK transcript (LOC647276) is expressed at the relatively high level and overrepresented in tumor samples. To our surprise, experimental study of human asLZK revealed that this sequence is not expressed, but represents a silent pseudogene of ribosomal protein L4 encoding gene RPL4. This pseudogene resulted from relatively recent retroposition of RPL4 mRNA into the first intron of MAP3K13 gene and does not participate in the regulation of MAP3K13 expression. This study stresses that, after initial in silico mapping efforts, experimental verification of the expression landscape is warranted.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , Quinasas Quinasa Quinasa PAM/biosíntesis , Proteínas de Neoplasias/biosíntesis , Neoplasias/metabolismo , ARN sin Sentido/biosíntesis , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Intrones/genética , Quinasas Quinasa Quinasa PAM/genética , Proteínas de Neoplasias/genética , Neoplasias/genética , Seudogenes/genética , ARN sin Sentido/genética , Retroelementos/genética , Proteínas Ribosómicas/biosíntesis , Proteínas Ribosómicas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...